Bengaluru — Pharma group Eli Lilly raised its 2019 earnings forecast on Tuesday and reported second-quarter profit that topped Wall Street estimates.

Higher demand for newer drugs offset increased discounts for the US Medicare programme and sales declines of medicines that have lost patent protection...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now